Pharmaceutical

STAT+: Pharmalittle: Pharma execs call for reversal of ...

A dueling pair of federal court decisions on the abortion pill mifepristone has ...

STAT+: A biotech upstart takes on cancer by crowdsourci...

ImmuneBridge, a San Francisco-based startup, is developing cancer immunotherapie...

Opinion: Current heat warning systems are woefully inad...

Currently, weather warnings for heat are issued based on the probability and mag...

6 burning questions about how the FDA will handle confl...

The FDA's drug approval process the “should stay as untouched by threats of liti...

STAT+: ‘It was my call’: Stanford president defends dec...

Stanford president Marc Tessier-Lavigne took responsibility for the decision not...

Where is PhRMA in the mifepristone debate?

PhRMA hasn’t put out a press release about a Texas judge suspending approval for...

Next abortion battles may be among states with clashing...

“If red states pass laws saying, ‘We can go after people for X, Y and Z,’ and bl...

STAT+: Pharmalittle: Abortion pill ruling could threate...

A federal judge's ruling to revoke longstanding FDA approval of the abortion pil...

STAT+: 5 to watch: Tech startups trying to solve health...

Staffing — and in particular, hiring nurses — is still a top concern for hospita...

Here’s a new data point for cancer patients to consider...

“As an oncologist, patients rely on us to convey to them the relative risks and ...

STAT+: UnitedHealth’s physician buying spree continues ...

UnitedHealth Group quietly acquired Crystal Run Healthcare, a physician group in...

Opinion: Why genetic testing should always be offered t...

These tests save families valuable time, helping them get to a diagnosis faster.

STAT+: Competing abortion pill rulings sow broad alarm,...

Competing rulings on the abortion pill from judges in Texas and Washington on th...

STAT+: FDA warns some Philips respirators may not deliv...

Some Philips respirators were incorrectly programmed with the wrong serial numbe...

Aviceda, QUB to develop next-generation glyco-immune th...

Aviceda’s HALOS is used to modulate the innate immune system to develop next-gen...

Malaysia approves additional indication for Astrazeneca...

Evusheld is intended to treat adult and adolescent Covid-19 patients aged 12 yea...